clinical remissions

Trending/clinical remissions

Drug Induces Morphologic, Molecular and Clinical Remissions in Myelofibrosis

Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis. Hematologist and lead author…

No information found.

Sign up